Muscat Rehabilitation Centre opens in Al Amerat
Dr. Yousef Al-Farsi, Director General of Muscat Health, emphasized that the centre represents a substantial advancement in Oman's mental and social healthcare system. It is designed to offer a comprehensive suite of specialized treatment and rehabilitation services for addiction recovery, providing a secure therapeutic environment and robust programs built on a rigorous scientific approach. These programs are aimed at empowering individuals towards positive change and utilize the latest global methods and technologies. Treatment follows a graduated plan, beginning with medically supervised detoxification, progressing to a short-term rehabilitation phase focused on psychological support and self-stability, and culminating in a long-term rehabilitation phase. The ultimate goal of this long-term phase is to help individuals rebuild healthy, stable lifestyles and effectively reintegrate into society. Dr. Al-Farsi concluded that this holistic approach creates genuine opportunities for a return to normal, healthy life, thereby directly contributing to community safety and psychological stability.
Petroleum Development Oman (PDO) and Al Jisr Foundation highlighted their integral roles in bringing the centre to fruition. Eng. Mohammed Ali Al Aghbari, PDO's External Affairs, Government Relations and Communications Manager, stated that the centre's launch is a crucial step in advancing mental and behavioural healthcare services in Oman, expressing pride in PDO's partnership with the Ministry of Health and Al Jisr Foundation. He noted PDO's commitment to ensuring the centre meets national expectations and delivers meaningful social impact, aligning with Oman Vision 2040. Jumana Al-Zadjali, Initiatives and Charitable Projects Officer at Al Jisr Foundation, further underscored the centre as a milestone in addiction treatment and rehabilitation in Oman, representing a progressive stride towards a healthier and more cohesive society. She stressed that the centre is a testament to comprehensive partnership among public, private, and civil sectors, uniting efforts to serve a vital segment of the population in urgent need of support and safe reintegration.
The Muscat Rehabilitation Centre offers a wide array of services, including medical, psychological, social, physiotherapy, and vocational therapy. Equipped with cutting-edge global technologies and practices in addiction recovery, it aims to mitigate the adverse effects of addiction and bolster Oman's broader anti-substance abuse initiatives. The project's first phase was funded by PDO with OMR 2.5 million, while Al Jisr Foundation contributed OMR 900,000 for the second phase, bringing the total cost to OMR 3.4 million. The Ministry of Health provided full outfitting, including furniture, medical devices, and IT equipment.
The establishment of this centre responds to the escalating demand for expanded preventive, therapeutic, and rehabilitative services for individuals grappling with addiction, offered by the Ministry of Health. It also focuses on providing essential aftercare services and supporting patient reintegration into society. This collaborative effort among governmental, private, and civil society institutions aims to reduce stigma and fortify community support for affected individuals. Furthermore, the centre strategically eases the burden on other hospitals and reaffirms Oman's dedication to achieving the goals of Oman Vision 2040, particularly the objective of fostering a society with sustainable health and high-quality preventive and curative healthcare services.
The Muscat Rehabilitation Center features five inpatient wards with a total capacity of 130 beds, comprising 96 for males and 34 for females. These include two detoxification units (20 male, 10 female beds) and two short-term rehabilitation units (66 male, 24 female beds). Additionally, the centre houses a forensic medicine department for men with 10 beds for compulsory treatment referrals and integrates services from the Rehabilitation House Center for a seven-month long-term program, offering up to 40 beds. Supporting facilities encompass a reception, registration, examination department, outpatient clinics with four consultation rooms, dedicated clinics for psychologists and social workers, a laboratory, pharmacy, security building, a multipurpose hall, vocational training workshops, and recreational areas.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times of Oman
2 days ago
- Times of Oman
Operation Chivalrous Knight 3 delivers medicines, medical supplies to support Gaza's health sector
Gaza: The UAE, in cooperation with the World Health Organisation (WHO) in the Gaza Strip, has delivered a shipment of medicines and medical supplies to the health sector, as part of Operation Chivalrous Knight 3. The aid will be distributed to hospitals and medical facilities to help address acute shortages and strengthen their ability to respond to emergencies. Among the recipients was Nasser Medical Complex in Khan Younis, which received several truckloads carrying essential medicines and critical supplies. The delivery aims to boost the hospital's capacity to handle urgent cases at a time when it is facing severe shortages of medicines and equipment. Sharif Al-Nayrab, Media Director for Operation Chivalrous Knight 3 in Gaza, reaffirmed that the UAE continues to provide medical aid and pharmaceuticals to the Gaza Strip under the initiative to prevent the collapse of the healthcare system and alleviate the suffering of hospitals and patients. Heba Alnajjar, Emergency medical teams (EMT) coordinator at WHO, stated that the organisation delivered the shipment to the Palestinian Ministry of Health, containing all essential and currently unavailable medicines in Gaza's health facilities. She expressed hope for continued cooperation and the entry of more UAE aid to support the health sector. Ibrahim Al-Farra, Director of the Palestinian Aid Delivering Committee at the Ministry of Health in Gaza, described the UAE's assistance as a "lifeline" for all patients, noting that the continued supply of medicines and medical equipment revitalises hospitals and helps save the lives of the sick and wounded. The delivery is part of an ongoing series of aid shipments scheduled for the coming period, as part of the UAE's sustained efforts through Operation Chivalrous Knight 3 to ease the health crisis in Gaza and ensure the continuity of medical services.
Times of Oman
3 days ago
- Times of Oman
Agreement inked to provide low-income segments with home ventilators
Muscat: The Ministry of Health on Thursday signed a funding agreement with Oman India Fertilizer Company (OMIFCO) to purchase ventilators for patients from low-income and social security segments. The agreement was signed by Saud Amer Al Nudhairi, the Ministry's Director General of Financial Affairs, and Khalid Mohammed Al Fannah Al Araimi, OMIFCO's Director of Sustainability and Institutional Communication. Al Nudhairi stressed the importance of partnerships between the government sector and other sectors in the Sultanate of Oman to serve members of the public. He hailed the company's noble initiative which, he observed, has been undertaken for the sixth time in a row. For his part, Al Araimi expressed his appreciation for the Health Ministry's ongoing partnership in supporting needy segments of society. The devices minimises the need for hospitalisation, improves the quality of life for patients and provides better monitoring and control of health conditions. They are an essential part of some home care programmes as they provide a safe and sustainable option for some patients who require long-term mechanical ventilation outside the hospital.
Times of Oman
4 days ago
- Times of Oman
10,000 patients benefit from early retinopathy screening programme in various governorates
Muscat: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies has successfully screened over 10,000 eligible patients. This achievement reflects the programme's rapid implementation and its impact on preventing retinopathy complications and protecting diabetic patients from the risk of vision loss. The AI-powered national screening programme has expanded its services to 25 health centres across all governorates of the Sultanate of Oman. This expansion is part of national efforts to enhance ophthalmology services, leverage modern technologies, and utilise AI to support early diagnosis and ensure timely access to screening and treatment. Dr. Majid Salim Al Shaibani, Retina and Intraocular Inflammation Consultant at Al Nahdha Hospital and Operational Director of the National Diabetic Retinopathy Screening Program, told Oman News Agency (ONA): 'Since the programme's nationwide launch, we have screened over 10,000 patients in less than six months, detecting numerous retinopathy cases at early stages before noticeable symptoms appeared." He added that preliminary data indicates a detection rate exceeding 30% of screened cases—a level of effectiveness unattainable before the introduction of AI technologies. Dr. Al Shaibani explained that diabetic retinopathy is a silent disease in its early stages, often diagnosed only after serious complications arise. Early detection enables prompt intervention, whether through close monitoring, laser treatment, or intraocular injections, significantly reducing the risk of progression to advanced stages that may cause permanent blindness. This aligns with global recommendations to prevent diabetes-related blindness. Regarding referral mechanisms, he noted that the programme is electronically linked to the national health records system (Shifa), allowing detected cases requiring further evaluation or treatment to be directly referred to specialised eye clinics in reference hospitals. Priority is determined based on severity to ensure urgent cases receive timely care. He pointed out that the program utilizes globally approved AI systems for retinal image analysis, capable of detecting various stages of diabetic retinopathy. These advanced deep-learning algorithms provide results within seconds of image capture. The AI models were trained on hundreds of thousands of high-quality global images and validated across diverse populations, with local verification conducted at Oman's dedicated reading center to ensure clinical accuracy. Dr. Al Shaibani highlighted plans to develop a localised AI database incorporating demographic and epidemiological characteristics to improve diagnostic precision. The program also coordinates with periodic diabetes check-ups, integrating retinopathy screening with other essential tests (e.g., diabetic foot exams, kidney function, blood pressure) into a single visit for patient convenience. He underlined awareness campaigns targeting diabetic patients through clinic staff, electronic reminders, social media, and educational materials to stress the dangers of delayed screening. Parallel community outreach initiatives aim to increase participation and encourage pre-symptomatic testing. As the third country globally to implement such an AI-driven initiative, Oman demonstrates its commitment to adopting cutting-edge technologies for enhanced diagnostic accuracy, cost efficiency, and timely intervention. The programme covers all Type 1 and Type 2 diabetes patients, playing a pivotal role in preventing vision loss through early detection.
